We are a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability, positioning us well to maximise the value we create for our business and our diverse stakeholders.
We supply medicines to more than 150 countries and have 69 established business offices in more than 50 countries. We focus on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets.
OUR INVESTMENT CASE
Our vision inspires our actions
To deliver value to our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines globally.
Commercial and sales employees:
in emerging countries
in developed countries
Medicines supplied to more than
130 emerging and over 25 developed
Gross profit by business segment (%)
SHARE PRICE CENTRE
View share price information for Aspen Holdings.
APN ISIN: ZAE 000066692
JSE data delayed by 15 minutes, page refreshes every 5 minutes. Indicated trade times are actual.
All capital distributions to date
Analysis of shareholders at 30 June 2019
All corporate information and contact details
REGISTER FOR ALERTS
March 2022 Interim results SENS announcement
March 2022 Interim results presentation
March 2022 JP Morgan South African Healthcare Seminar (virtual)
March 2022 Bank of America Securities 23rd Annual Sun City Conference (virtual)
August 2022 Annual results SENS announcement
September 2022 Annual results presentation
September 2022 13th Annual RMB Morgan Stanley Big Five Investor Conference
December 2022 Annual General Meeting